JO
QGENF

John Overdeck’s QIAGEN NV QGENF Stock Holding History

John Overdeck’s Portfolio QGENF Stock Details QGENF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-720,811
Closed -$20.2M – 3618
2016
Q4 		$20.2M Sell
720,811
-18,660
-3% -$523K 0.08% 307
2016
Q3 		$20.3M Buy
739,471
+467,992
+172% +$12.8M 0.07% 301
2016
Q2 		$5.92M Sell
271,479
-517,087
-66% -$11.3M 0.03% 703
2016
Q1 		$17.6M Buy
788,566
+766,436
+3,463% +$17.1M 0.08% 286
2015
Q4 		$612K Sell
22,130
-39,453
-64% -$1.09M ﹤0.01% 1844
2015
Q3 		$1.59M Sell
61,583
-65,354
-51% -$1.69M 0.01% 946
2015
Q2 		$3.15M Sell
126,937
-3,463
-3% -$85.9K 0.01% 944
2015
Q1 		$3.29M Buy
+130,400
New +$3.29M 0.02% 916
2014
Q1 		– Sell
-278,982
Closed -$6.64M – 2596
2013
Q4 		$6.64M Buy
+278,982
New +$6.64M 0.04% 544

Other funds holding QGENF

BJCM
Blue Jay Capital Management Los Angeles, California $147M AUM 64.18% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
GAM
Gotham Asset Management New York $43B AUM 34.97% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Capital Fund Management (CFM)
Capital Fund Management (CFM) Paris, France $22.7B AUM 32.92% 1-Year Est. Return
Twin Tree Management
Twin Tree Management Dallas, Texas $5.31B AUM 55.82% 1-Year Est. Return

John Overdeck's QGENF Position: Q1 2017 in Review

John Overdeck sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 720,811 shares — an estimated $20.2M sold.

John Overdeck first reported a position in QGENF in Q4 2013 and held it in 9 quarters. The position peaked at $20.3M in Q3 2016. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • John Overdeck reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • John Overdeck sold 720,811 QIAGEN NV shares in Q1 2017, an estimated $20.2M.
  • John Overdeck first reported a position in QIAGEN NV in Q4 2013 and held it in 9 quarters.
  • John Overdeck's QIAGEN NV position peaked at $20.3M in Q3 2016.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on Two Sigma Investments's 13F filing for Q1 2017, filed 15 May 2017.